Furthermore, we found that PRDX1 silencing abolished the increase in the level of neddylated CUL5 protein induced by etoposide, increasing the sensitivity of CRC cells to etoposide treatment (Fig. 7). The gene discussed is PRDX1; the disease is colorectal carcinoma.